Defining the Clinical Course of Metastatic Skin Cancer in Organ Transplant Recipients
Open Access
- 1 March 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (3) , 301-306
- https://doi.org/10.1001/archderm.139.3.301
Abstract
ORGAN TRANSPLANT recipients are known to have increased susceptibility to and a higher incidence of skin cancer than the general population.1-4 In addition to occurring more often, the cutaneous malignancies that occur in these patients tend to have a more aggressive clinical course. Skin cancers in organ transplant recipients have a greater tendency to metastasize distantly and are associated with higher mortality than skin cancer in the general population.2,5Keywords
This publication has 7 references indexed in Scilit:
- Organization of a Specialty Clinic to Optimize the Care of Organ Transplant Recipients at Risk for Skin CancerDermatologic Surgery, 2000
- High Incidence and Clinical Course of Aggressive Skin Cancer in Heart Transplant Patients: A Single-Center StudyTransplantation Proceedings, 1998
- Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensThe Lancet, 1998
- Skin cancer in heart transplant recipientsJournal of the American Academy of Dermatology, 1995
- Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for managementBritish Journal of Plastic Surgery, 1994
- Clinical course of malignancies in renal transplant recipientsCancer, 1993
- Skin cancer in renal transplant recipientsBritish Journal of Surgery, 1989